Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-21

Clinical Trial Update: Mesenchymal Stem Cells in Osteonecrosis of the Femoral Head [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating mesenchymal stem cells for avascular necrosis of the femoral head has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Banc de Sang i Teixits | Conditions: Avascular Necrosis of Femur Head | Phase 1, Phase 2 | Status: COMPLETED